secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001723128-25-000024
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

All Amneal director nominees elected, say-on-pay approved at annual meeting
---------------------------------------------------------------------------

- 11 directors elected with overwhelming support; Paul Meister received lowest 'For' count at 239.8M shares.
- Advisory vote on executive compensation passed with 258.8M votes for vs 1.3M against.
- Stockholders selected 1 year as frequency for future say-on-pay votes (255.1M votes for 1 year).
- Ratification of Ernst & Young as auditor for FY2025 approved with 289.0M votes for, 0.5M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000172312825000024/0001723128-25-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000172312825000024/amrx-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001723128-25-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer